Search research articles
Contact Us
Filters
Showing results (61-70 of 104) with videos related to
Page
of 11
Sort By:
American Journal of Hematology
|
January 31, 2017
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
Madlen Jentzsch, Marius Bill, Deedra Nicolet, et al.
Haematologica
|
June 12, 2013
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline
Jason H Mendler, Kati Maharry, Heiko Becker, et al.
Oncotarget
|
August 13, 2016
Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Ramasamy Santhanam, et al.
The AAPS Journal
|
November 27, 2012
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemia
Hongyan Wang, Ping Chen, Jiang Wang, et al.
Blood
|
August 11, 2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
Sebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, et al.
Journal of Cancer Research and Clinical Oncology
|
August 23, 2017
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)
Juliane Beck, Andreas Schwarzer, Dietrich Gläser, et al.
Leukemia
|
August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Michael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 23, 2009
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study
Heiko Becker, Guido Marcucci, Kati Maharry, et al.
Bone Marrow Transplantation
|
June 3, 2026
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells
Simon M Krauß, Konstantin Weibl, Enrica Bach, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 104) with videos related to
Sort By:
Page
of 11
American Journal of Hematology
|
January 31, 2017
Prognostic impact of the CD34+/CD38- cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation
Madlen Jentzsch, Marius Bill, Deedra Nicolet, et al.
Haematologica
|
June 12, 2013
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline
Jason H Mendler, Kati Maharry, Heiko Becker, et al.
Oncotarget
|
August 13, 2016
Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Ramasamy Santhanam, et al.
The AAPS Journal
|
November 27, 2012
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemia
Hongyan Wang, Ping Chen, Jiang Wang, et al.
Blood
|
August 11, 2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
Sebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, et al.
Journal of Cancer Research and Clinical Oncology
|
August 23, 2017
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)
Juliane Beck, Andreas Schwarzer, Dietrich Gläser, et al.
Leukemia
|
August 1, 2020
Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
Michael Heuser, Neil Palmisiano, Ioannis Mantzaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia
Xiaomeng Huang, Sebastian Schwind, Bo Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 23, 2009
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study
Heiko Becker, Guido Marcucci, Kati Maharry, et al.
Bone Marrow Transplantation
|
June 3, 2026
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells
Simon M Krauß, Konstantin Weibl, Enrica Bach, et al.
Page
of 11